{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:44:51Z","timestamp":1789771491456,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007312","name":"Cleveland Clinic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R00-AI141742"],"award-info":[{"award-number":["R00-AI141742"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["DP2-AI170515"],"award-info":[{"award-number":["DP2-AI170515"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.coviro.2025.101491","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:45:57Z","timestamp":1758602757000},"page":"101491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Virological and immunological determinants of hepatitis E virus infection outcomes"],"prefix":"10.1016","volume":"73","author":[{"given":"Xinjia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hee","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"O\u2019Shaughnessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2995-935X","authenticated-orcid":false,"given":"Xianfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2025.101491_bib1","unstructured":"World Health Organization: Global hepatitis report; 2017."},{"key":"10.1016\/j.coviro.2025.101491_bib2","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2025.101491_sbref2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis C virus infection","volume":"3","author":"Manns","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.coviro.2025.101491_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/v8080212","article-title":"Hepatitis E pathogenesis","volume":"8","author":"Lhomme","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2025.101491_bib6","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/v15061389","article-title":"Hepatitis E virus infections: epidemiology, genetic diversity, and clinical considerations","volume":"15","author":"Songtanin","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2025.101491_bib7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2025.101491_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005695","article-title":"Expanding host range and cross-species infection of hepatitis E virus","volume":"12","author":"Meng","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2025.101491_bib9","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031872","article-title":"Acute and persistent hepatitis E virus genotype 3 and 4 infection: clinical features, pathogenesis, and treatment","volume":"9","author":"Kamar","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coviro.2025.101491_sbref9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2025.101491_bib11","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jhep.2014.08.047","article-title":"The impact of hepatitis E in the liver transplant setting","volume":"61","author":"Behrendt","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib12","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031724","article-title":"Hepatitis E virus genome structure and replication strategy","volume":"9","author":"Kenney","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coviro.2025.101491_bib13","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/cells9051294","article-title":"On the host side of the hepatitis E virus life cycle","volume":"9","author":"Oechslin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.coviro.2025.101491_bib14","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1099\/vir.0.035378-0","article-title":"Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions","volume":"92","author":"Nagashima","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2025.101491_bib15","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1099\/vir.0.066910-0","article-title":"Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies","volume":"95","author":"Nagashima","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2025.101491_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104824","article-title":"Hepatitis B virus cccDNA: formation, regulation and therapeutic potential","volume":"180","author":"Xia","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2025.101491_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2016.08.009","article-title":"The role of quantitative hepatitis B surface antigen revisited","volume":"66","author":"Cornberg","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib18","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1073\/pnas.1721345115","article-title":"Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection","volume":"115","author":"Yin","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2025.101491_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010798","article-title":"An Arginine-Rich Motif in the ORF2 capsid protein regulates the hepatitis E virus lifecycle and interactions with the host cell","volume":"18","author":"Hervouet","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2025.101491_bib20","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1128\/jvi.66.5.3225-3229.1992","article-title":"Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution","volume":"66","author":"Martell","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2025.101491_bib21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/0042-6822(91)90104-J","article-title":"Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins","volume":"180","author":"Weiner","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2025.101491_bib22","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/gutjnl-2015-311000","article-title":"In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome","volume":"65","author":"Todt","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.coviro.2025.101491_bib23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jhep.2004.12.013","article-title":"The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection?","volume":"42","author":"Bowen","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41579-023-00889-z","article-title":"Cell entry and release of quasi-enveloped human hepatitis viruses","volume":"21","author":"Das","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coviro.2025.101491_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.gastro.2017.10.041","article-title":"Pan-genotype hepatitis E virus replication in stem cell\u2013derived hepatocellular systems","volume":"154","author":"Wu","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2025.101491_bib26","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1073\/pnas.1912307117","article-title":"Robust hepatitis E virus infection and transcriptional response in human hepatocytes","volume":"117","author":"Todt","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2025.101491_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006417","article-title":"Hepatitis E virus persists in the presence of a type III interferon response","volume":"13","author":"Yin","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2025.101491_bib28","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2018.01.034","article-title":"Hepatitis B virus does not interfere with innate immune responses in the human liver","volume":"154","author":"Suslov","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2025.101491_bib29","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2025.101491_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/v12030285","article-title":"The interactions between HBV and the innate immunity of hepatocytes","volume":"12","author":"Megahed","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2025.101491_sbref30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2025.101491_bib32","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2025.101491_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.740464","article-title":"Host innate immunity against hepatitis viruses and viral immune evasion","volume":"12","author":"Xu","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2025.101491_bib34","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/hep.25530","article-title":"Suppression of interferon-\u03b1 signaling by hepatitis E virus","volume":"55","author":"Dong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2025.101491_bib35","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1128\/JVI.02571-08","article-title":"The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics","volume":"83","author":"Kannan","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2025.101491_sbref35","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1073\/pnas.1614955114","article-title":"Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles","volume":"114","author":"Ding","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2025.101491_bib37","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.4014\/jmb.1808.08058","article-title":"Hepatitis E virus methyltransferase inhibits type i interferon induction by targeting RIG-I","volume":"28","author":"Kang","year":"2018","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.coviro.2025.101491_bib38","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1128\/JVI.01935-14","article-title":"Hepatitis E virus inhibits type I interferon induction by ORF1 products","volume":"88","author":"Nan","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2025.101491_bib39","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/sj.emboj.7600664","article-title":"The macro domain is an ADP-ribose binding module","volume":"24","author":"Karras","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2025.101491_bib40","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2022.05.019","article-title":"Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection","volume":"77","author":"Kemming","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib41","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jhep.2019.07.018","article-title":"Paving the way for T cell-based immunotherapies in chronic hepatitis E","volume":"71","author":"Neumann-Haefelin","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib42","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033472","article-title":"Adaptive immune responses in hepatitis A virus and hepatitis E virus infections","volume":"9","author":"Walker","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coviro.2025.101491_bib43","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1128\/JVI.78.11.5535-5545.2004","article-title":"Memory CD8 T-cell differentiation during viral infection","volume":"78","author":"Wherry","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2025.101491_sbref43","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","article-title":"Adaptive immune responses in acute and chronic hepatitis C virus infection","volume":"436","author":"Bowen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2025.101491_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cell.2009.06.036","article-title":"Redefining chronic viral infection","volume":"138","author":"Virgin","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2025.101491_sbref45","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2023.12.016","article-title":"Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection","volume":"80","author":"Csernalabics","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/jvh.12495","article-title":"Cross-genotype-specific T-cell responses in acute hepatitis E virus (HEV) infection","volume":"23","author":"Gisa","year":"2016","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.coviro.2025.101491_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coviro.2025.101491_bib49","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jhep.2022.08.002","article-title":"The pivotal role of CD8+ T cells in hepatitis E virus infection","volume":"77","author":"Br\u00fcggemann","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2025.101491_bib51","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"EASL Clinical Practice Guidelines on hepatitis E virus infection","volume":"68","author":"Dalton","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_sbref51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-57182-1","article-title":"Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice","volume":"16","author":"Ssebyatika","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2025.101491_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2025.06.015","article-title":"Antibodies elicited by hepatitis E vaccination in humans confer cross-genus protection against rat hepatitis E virus","author":"Chen","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib54","article-title":"Humoral immunity in hepatitis B virus infection:\u00a0rehabilitating the B in HBV","volume":"4","author":"Vanwolleghem","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.coviro.2025.101491_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0016-5085(99)70237-4","article-title":"Limited humoral immunity in hepatitis C virus infection","volume":"116","author":"Chen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2025.101491_sbref55","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2025.101491_bib57","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2025.101491_bib58","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/v9040075","article-title":"HBV DNA integration: molecular mechanisms and clinical implications","volume":"9","author":"Tu","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2025.101491_bib60","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1053\/j.gastro.2018.03.020","article-title":"Secretion of hepatitis C virus replication intermediates reduces activation of Toll-like receptor 3 in hepatocytes","volume":"154","author":"Gr\u00fcnvogel","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2025.101491_bib61","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1128\/JVI.74.2.944-955.2000","article-title":"In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease","volume":"74","author":"Chang","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2025.101491_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002881","article-title":"Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate","volume":"8","author":"Ribeiro","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2025.101491_bib63","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/lt.21480","article-title":"Chronic hepatitis E virus infection in liver transplant recipients","volume":"14","author":"Haagsma","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.coviro.2025.101491_bib64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TP.0b013e3181c4096c","article-title":"Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation","volume":"89","author":"Kamar","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.coviro.2025.101491_bib65","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2025.101491_bib66","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ekir.2024.01.054","article-title":"Relevance of Tacrolimus trough concentration and hepatitis E virus genetic changes in kidney transplant recipients with chronic hepatitis E","volume":"9","author":"Le\u00f3n-Janampa","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.coviro.2025.101491_sbref66","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2025.101491_bib68","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid\/1706.101067","article-title":"Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland","volume":"17","author":"Kenfak-Foguena","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2025.101491_sbref68","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jhep.2020.01.012","article-title":"HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis","volume":"72","author":"Tseng","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_bib70","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/jhep.2002.34856","article-title":"Hepatitis E virus superinfection in patients with chronic liver disease","volume":"36","author":"Hamid","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2025.101491_bib71","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(23)02234-1","article-title":"Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"403","author":"Huang","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2025.101491_bib72","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2025.101491_bib73","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1086\/650488","article-title":"Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation","volume":"50","author":"Kamar","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2025.101491_bib74","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jhep.2020.05.020","article-title":"Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E \u2013\u00a0the HepNet SofE pilot study","volume":"73","author":"Cornberg","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2025.101491_sbref74","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jhep.2016.09.014","article-title":"Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection","volume":"66","author":"van der Valk","year":"2017","journal-title":"J Hepatol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625725000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625725000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:49:06Z","timestamp":1772894946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625725000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":75,"alternative-id":["S1879625725000410"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2025.101491","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virological and immunological determinants of hepatitis E virus infection outcomes","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2025.101491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101491"}}